As of 2025-03-18, the Relative Valuation of Hollister Biosciences Inc (HOLL.CN) is 0.01 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.15 CAD, the upside of Hollister Biosciences Inc based on Relative Valuation is -93.4%.
The range of the Relative Valuation is 0.01 - 0.04 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.5x - 2.3x | 0.6x |
| Forward P/E multiples | 0.5x - 2.3x | 0.6x |
| Fair Price | 0.01 - 0.04 | 0.01 |
| Upside | -94.5% - -74.8% | -93.4% |
| Date | P/E |